These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16121812)

  • 1. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac metabolism in ischemic heart disease.
    Opie LH
    Arch Mal Coeur Vaiss; 1999 Dec; 92(12):1755-60. PubMed ID: 10665328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic intervention for the ischemic and post-ischemic heart.
    Svedjeholm R; Håkanson E; Szabó Z
    Wien Klin Wochenschr; 1999 Jul; 111(13):501-11. PubMed ID: 10444803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological modulation of mitochondrial function during ischemia and reperfusion.
    Monteiro P; Oliveira PJ; Conçalves L; Providência LA
    Rev Port Cardiol; 2003 Mar; 22(3):407-29. PubMed ID: 12847881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of cytochrome c on the myocardium during reperfusion].
    Boiarinov GA; Iakovlev AIu; Teziaeva SA; Mukhina IV; Boiarinova LV
    Patol Fiziol Eksp Ter; 1999; (4):20-5. PubMed ID: 10598459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?
    Lopaschuk GD
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S8-11. PubMed ID: 11286307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
    Sack MN; Yellon DM
    J Am Coll Cardiol; 2003 Apr; 41(8):1404-7. PubMed ID: 12706939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The current aspects of the pharmacological protection of the ischemic myocardium].
    Chichkanov GG
    Eksp Klin Farmakol; 1994; 57(6):15-20. PubMed ID: 7756948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic considerations in the treatment of coronary disease in diabetic patients].
    Piot C
    Diabetes Metab; 2001 Nov; 27(5 Pt 2):S25-9. PubMed ID: 11910982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of a polypeptide drug on the state of energy metabolism of myocardial cells in hypoxic and ischemic conditions].
    Pavlenko VS; Ershov VI; Andreeva LI; Kazantseva ST; Khavinson VKh
    Biull Eksp Biol Med; 1991 Jul; 112(7):24-7. PubMed ID: 1793841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of a cardiac peptide preparation on the myocardium in ischemia].
    Pavlenko VS; Andreeva LI; Khavinson VKh; Khlystov VV; Gutsol AA
    Biull Eksp Biol Med; 1990 Aug; 110(8):127-9. PubMed ID: 2291951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
    Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
    Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the vascular wall and ischemic damages to the myocardium in reversible episodes of heart muscle ischemia].
    Pozin VM; Skuratovskaia SG; Pocheptsova GA
    Fiziol Zh (1994); 1996; 42(1-2):10-6. PubMed ID: 8991704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
    Labrid C
    Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New thoughts of pathophysiology and therapy of ischemic heart disease.
    Pepine CJ
    Cardiologia; 1991 Dec; 36(12 Suppl 1):373-7. PubMed ID: 1841793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of L-carnitine on ischemic heart disease: experimental results].
    Lerch R
    Praxis (Bern 1994); 1998 Jan; 87(4):97-100. PubMed ID: 9522638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ATP-preserving effect of histochrome during acute myocardial ischemia in patients with ischemic heart disease].
    Afanasiev SA; Lasukova TV; Cherniavskiĭ AM
    Biull Eksp Biol Med; 1997 Dec; 124(12):669-71. PubMed ID: 9483324
    [No Abstract]   [Full Text] [Related]  

  • 19. [The anti-ischemic properties of new specific bradycardic agents, derivatives of 2-mercaptobenzimidazole].
    Chichkanov GG; Tsorin IB; Kirsanova GIu
    Eksp Klin Farmakol; 1998; 61(6):20-4. PubMed ID: 9929811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The current possibilities for the pharmacological regulation of myocardial metabolism in experimental catecholamine-induced necroses].
    Sysoliatina NA; Artamonova VV
    Eksp Klin Farmakol; 1998; 61(1):70-3. PubMed ID: 9575418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.